White House says FDA's approval of generic abortion pill is not an endorsement by administration
NeutralU.S News

The White House clarified that the FDA's recent approval of a generic version of the abortion pill mifepristone does not imply an endorsement from the administration. This distinction is important as it highlights the ongoing debate surrounding reproductive rights and the use of abortion medications in the U.S., ensuring that the approval is viewed in the context of regulatory processes rather than political support.
— Curated by the World Pulse Now AI Editorial System